Home / Inspections / 1072906

FDA Inspection 1072906 — Renata Sienkiewicz-Kozlowska, MD

Renata Sienkiewicz-Kozlowska, MD — FEI 3014522519

The FDA completed an inspection of Renata Sienkiewicz-Kozlowska, MD on Oct 26, 2018 in Warsaw. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 26, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Warsaw (Poland)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.